| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD8899 | CTRPv2 | pan-cancer | AAC | -0.0013 | 1 |
| mRNA | nintedanib | CTRPv2 | pan-cancer | AAC | -0.0011 | 1 |
| mRNA | CAY10594 | CTRPv2 | pan-cancer | AAC | 0.001 | 1 |
| mRNA | selumetinib:UNC0638 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.00078 | 1 |
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | -0.00077 | 1 |
| mRNA | I-BET-762 | GDSC1000 | pan-cancer | AAC | -0.00052 | 1 |
| mRNA | BRD-K27188169 | CTRPv2 | pan-cancer | AAC | -0.001 | 1 |
| mRNA | lapatinib | GDSC1000 | pan-cancer | AAC | -0.00079 | 1 |
| mRNA | BX-795 | GDSC1000 | pan-cancer | AAC | 0.00049 | 1 |
| mRNA | JW-480 | CTRPv2 | pan-cancer | AAC | -0.00053 | 1 |